Inhibitory effect of lidocaine on pain and itch using formalin-induced nociception and 5′-guanidinonaltrindole-induced scratching models in mice: Behavioral and neuroanatomical evidence

European Journal of Pharmacology

Volumn 616, Issue 1-3, 2009, Pages 141-146

  Inan, Saadet ^a   Dun, Nae J ^a   Cowan, Alan ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

C fos expression; Formalin; GNTI; Itch; Pain

Indexed keywords

FORMALDEHYDE; KAPPA OPIATE RECEPTOR ANTAGONIST; LIDOCAINE; LOCAL ANESTHETIC AGENT; PROTEIN C FOS;

ANALGESIA; ANALGESIC ACTIVITY; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CERVICAL SPINE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; DRUG RESPONSE; EVOKED RESPONSE; IMMUNOHISTOCHEMISTRY; LICKING; LOCOMOTION; LUMBAR SPINE; MALE; MOUSE; NECK; NERVE CELL; NEUROANATOMY; NOCICEPTION; NONHUMAN; PAIN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PRURITUS; SCRATCHING; SPINAL CORD DORSAL HORN; SWISS WEBSTER MOUSE;

ANIMALS; BEHAVIOR, ANIMAL; FORMALDEHYDE; GENE EXPRESSION REGULATION; GUANIDINES; LIDOCAINE; MALE; MICE; NALTREXONE; NEURONS; PAIN; PROTO-ONCOGENE PROTEINS C-FOS; PRURITUS; RECEPTORS, OPIOID, KAPPA;

EID: 67651085067     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2009.06.026     Document Type: Article

References (42)

1. Abbadie C., Taylor B.K., Peterson M.A., and Basbaum A.I. Differential contribution of the two phases of the formalin test to the pattern of c-fos expression in the rat spinal cord: studies with remifentanil and lidocaine. Pain 69 (1997) 101-110
2. Andrew D., and Craig A.D. Spinothalamic lamina I neurons selectively sensitive to histamine: a central neural pathway for itch. Nat. Neurosci. 4 (2001) 72-77
3. Binshtok A.M., Bean B.P., and Woolf C.J. Inhibition of nociceptors by TRPV1-mediated entry of impermeant sodium channel blockers. Nature 449 (2007) 607-610
4. Bittencourt A.L., and Takahashi R.N. Mazindol and lidocaine are antinociceptives in the mouse formalin model: involvement of dopamine receptor. Eur. J. Pharmacol. 330 (1997) 109-113
5. Black S.L., Chauvignac C., Grundt P., Miller C.N., Wood S., Traynor J.R., Lewis J.W., and Husbands S.M. Guanidino N-substituted and N, N-disubstituted derivatives of the kappa-opioid antagonist GNTI. J. Med. Chem. 46 (2003) 5505-5511
6. Bon K., Wilson S.G., Mogil J.S., and Roberts W.J. Genetic evidence for the correlation of deep dorsal horn Fos protein immunoreactivity with tonic formalin pain behavior. J. Pain 3 (2002) 181-189
7. Brailoiu G.C., Dun S.L., Ohsawa M., Yin D., Yang J., Chang J.K., Brailoiu E., and Dun N.J. Kiss-1 expression and metastatin-like immunoreactivity in the rat brain. J. Comp. Neurol. 481 (2005) 314-329
8. Choi S.S., Lee J.K., and Suh H.W. Antinociceptive profiles of aspirin and acetaminophen in formalin, substance P and glutamate pain models. Brain Res. 921 (2001) 233-239
9. Cowan A., and Inan S. Kappa-opioid antagonists as pruritogenic agents. In: Dean R.L., Bilsky E.J., and Negus S.S. (Eds). Opioid Receptors and Antagonists: from Bench to Clinic (Volume in the Contemporary Neuroscience Series (2009), Humana Press, New York, NY 533-542 Chapter 28
10. Craig A.D. How do you feel? Interoception: the sense of the physiological condition of the body. Nat. Rev. 3 (2002) 655-666
11. Cummins T.R., Sheets P.L., and Waxman S.G. The roles of sodium channels in nociception: implications for mechanisms for pain. Pain 131 (2007) 243-257
12. De los Santos-Artega M., Sierra-Dominguez S.A., Fontenalla G.H., Dalgado-Garcia J.M., and Carrión A.M. Analgesia induced by dietary restriction is mediated by the kappa-opioid system. J. Neurosci. 23 (2003) 11120-11126
13. Fishman S.M., Caneris O.A., Stojanovic M.P., and Borsook D. Intravenous lidocaine for treatment-resistant pruritus. Am. J. Med. 102 (1997) 584-585
14. Geha P.Y., Baliki M.N., Wang X., Harden R.N., Paice J.A., and Apkarian A.V. Brain dynamics for perception of tactile allodynia (touch-induced pain) in postherpetic neuralgia. Pain 138 (2008) 641-656
15. Hitosugi H., Kashiwazaki T., Ohsawa M., and Kamei J. Effects of mexiletine on algogenic mediator-induced nociceptive responses in mice. Methods Find. Exp. Clin. Pharmacol. 21 (1999) 409-413
16. Hunskaar S., Berge O.G., and Hole K. Antinociceptive effects of orphenadrine citrate in mice. Eur. J. Pharmacol. 111 (1985) 221-226
17. Jones R.M., and Portoghese P.S. 5-Guanidinonaltrindole, a highly selective and potent κ-opioid receptor antagonist. Eur. J. Pharmacol. 396 (2000) 49-52
18. Kopecky E.A., Jacobson S., Hubley P., Palozzi L., Clarke H.M., and Koren G. Safety and pharmacokinetics of EMLA in the treatment of postburn pruritus in pediatric patients: a pilot study. J. Burn Care Rehabil. 22 (2001) 235-242
19. Kuraishi Y., Nagasawa T., Hayashi K., and Satoh M. Scratching behavior induced by pruritogenic but not algesiogenic agents in mice. Eur. J. Pharmacol. 275 (1995) 229-232
20. Layton A.M., and Cotterill J.A. Notalgia paraesthetica: report of three cases and their treatment. Clin. Exp. Dermatol. 16 (1991) 197-198
21. Lim T.K.Y., MacLeod B.A., Ries C.R., and Schwarz S.K.W. The quaternary lidocaine derivative, QX-314, produces long-lasting local anesthesia in animal models in vivo. Anesthesiology 107 (2007) 305-311
22. Murray C.W., Porreca F., and Cowan A. Methodologic refinements to the mouse paw formalin test. An animal model of tonic pain. J. Pharmacol. Methods 20 (1988) 175-186
23. Nalamachu S., Cockett R.S., Gammaitoni A.R., and Gould E.M. A comparison of the lidocaine patch 5% vs naproxen 500 mg twice daily for the relief of pain associated with carpal tunnel syndrome: a 6-week, randomized, parallel-group study. Med. Gen. Med. 8 (2006) 33-42
24. Namer B., Carr R., Johanek L.M., Schmelz M., Handwerker H.O., and Ringkamp M. Separate peripheral pathways for pruritus in man. J. Neurophysiol. 100 (2008) 2062-2069
25. Sahebgharani M., Hossein-Abad A.A., and Zarrindast M.R. On the mechanism of carbamazepine-induced antinociception in the formalin test. Int. J. Neurosci. 116 (2006) 1097-1113
26. Sandtner W., Szendroedi J., Zarrabi T., Zebedin E., Hilber K., Glaaser I., Fozzard H.A., Dudley S.C., and Todt H. Lidocaine: a foot in the door of the inner vestibule prevents ultra-slow inactivation of a voltage-gated sodium channel. Mol. Pharmacol. 66 (2004) 648-657
27. Schmelz M., Schmidt R., Bickel A., Handwerker H.O., and Torebjörk H.E. Specific C-receptors for itch in human skin. J. Neurosci. 17 (1997) 8003-8008
28. Schmidt R., Schmelz M., Torebjörk H.E., and Handwerker H.O. Mechano-insensitive nociceptors encode pain evoked by tonic pressure to human skin. Neurosci. 98 (2000) 793-800
29. Shuttleworth D., Hill S., Marks R., and Connelly D.M. Relief of experimentally induced pruritus with a novel eutectic mixture of local anesthetic agents. Br. J. Dermatol. 119 (1988) 535-540
30. Staniland A.A., and McMahon S.B. Mice lacking acid-sensing ion channels (ASIC)1 or 2, but not ASIC3, show increased pain behavior in the formalin test. Eur. J. Pain 13 (2009) 554-563
31. Strichartz G. Molecular mechanisms of nerve block by local anesthetics. Anesthesiology 4 (1976) 421-441
32. Sun X., Yokoyama M., Mizobuchi S., Kaku R., Nakatsuka H., Takahashi T., and Morita K. The effects of pretreatment with lidocaine and bupivacaine on the spatial and temporal expression of c-fos protein in the spinal cord caused by plantar incision in the rat. Anesth. Analg. 98 (2004) 1093-1098
33. Taylor B.K., Peterson M.A., and Basbaum A.I. Persistent cardiovascular and behavioral nociceptive responses to subcutaneous formalin require peripheral nerve input. J. Neurosci. 15 (1995) 7575-7584
34. Tremont-Lukats I.W., Challapalli V., McNicol E.D., Lau J., and Carr D.B. Systemic administration of local anesthetics to relieve neuropathic pain: a systematic review and meta-analysis. Anesth. Analg. 101 (2005) 1738-1749
35. Vaccarino A.L., Tasker R.A., and Melzack R. Analgesia produced by normal doses of opioid antagonists alone and in combination with morphine. Pain 36 (1989) 103-109
36. Vadalouca A., Siafaka I., Argyra E., Vrachnou E., and Moka E. Therapeutic management of chronic neuropathic pain. Ann. NY Acad. Sci. 1088 (2006) 164-186
37. Villamil A.G., Bandi J.C., Galdame O.A., Gerano S., and Gadano A.C. Efficacy of lidocaine in the treatment of pruritus in patients with chronic cholestatic liver diseases. Am. J. Med. 118 (2005) 1160-1163
38. Wasner G., Kleinert A., Binder A., Schattschneider J., and Baron R. Postherpetic neuralgia: topical lidocaine is effective in nociceptor-deprived skin. J. Neurol. 252 (2005) 677-686
39. Wheeler H., Blackburn T.P., Russell N.J.W., and Cowan A. Effects of lidocaine or capsaicin on scratching and grooming induced in mice by centrally or peripherally injected bombesin. Ann. NY Acad. Sci. 525 (1988) 433-434
40. Wood J.N., Boorman J.P., Okuse K., and Baker M.D. Voltage-gated sodium channels and pain pathways. J. Neurobiol. 61 (2004) 55-71
41. Yashpal K., Mason M., McKenna J.E., Sharma S.K., James H.L., and Coderre T.J. Comparison of the effects of treatment with intrathecal lidocaine given before and after formalin on both nociception and fos expression in the spinal cord dorsal horn. Anesthesiology 88 (1998) 157-164
42. Zhao C.S., Tao Y.X., Tall J.M., Donovan D.M., Meyer R.A., and Raja S.N. Role of μ-opioid receptors in formalin-induced pain behavior in mice. Exp. Neurol. 184 (2003) 839-845